Kampanjeplan HBM Holdings Limited
Om selskapet HBM Holdings Limited
HBM Holdings Limited, биофармацевтическая компания клинической стадии, занимается открытием и разработкой дифференцированных терапевтических антител в областях иммунологии и онкологии. flere detaljerISIN | KYG4403H1002 |
---|---|
Industry | Biotechnology |
Sector | Health Care |
Валюта | hkd |
Валюта отчета | usd |
Сайт | https://www.harbourbiomed.com |
Цена ао | 1.26 |
Prisendring per dag: | +5.05% (1.98) |
---|---|
Prisendring per uke: | +15.56% (1.8) |
Prisendring per måned: | +74.79% (1.19) |
Prisendring over 3 måneder: | +38.67% (1.5) |
Prisendring over seks måneder: | +60% (1.3) |
Prisendring per år: | +18.86% (1.75) |
Prisendring over 3 år: | -74.57% (8.18) |
Prisendring over 5 år: | 0% (2.08) |
Prisendring over 10 år: | 0% (2.08) |
Prisendring siden begynnelsen av året: | +76.27% (1.18) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
DFA Emerging Markets Small Cap Series | 1129000 | 0.15 |
SPDR Portfolio Emerging Markets ETF | 675000 | 0.09 |
DFA Emerging Markets Core Equity Portfolio | 414000 | 0.05 |
SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF | 349000 | 0.05 |
Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF | 338000 | 0.04 |
Dimensional ETF Tr-Dimensional Emerging Markets Core Equity 2 ETF | 226000 | 0.03 |
DFA Investment Dimensions-World Ex U.S. Core Equity Port | 148000 | 0.02 |
SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 81842 | 0.01 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
SPDR S&P China ETF | 0.00944 | 17.02 | 3.40103 |
SPDR S&P Emerging Markets Small Cap ETF | 0.00529 | 5.46 | 3.03583 |
Dimensional Emerging Markets Value ETF | 0.00293 | 17.07 | 4.19508 |
Dimensional Emerging Markets Core Equity 2 ETF | 0.00271 | 15.96 | 3.34087 |
SPDR Portfolio Emerging Markets ETF | 0.00109 | 11.59 | 3.1879 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Dr. Jingsong Wang M.D., Ph.D. | Founder, Chairman & CEO | 103.79M | 1965 (60 år) |
Dr. Yiping Rong Ph.D. | Chief Scientific Officer & Executive Director | N/A | 1978 (47 år) |
Dr. Peter F. Moesta Ph.D. | Member of Scientific Advisory Board & Chief CMC Advisor | N/A | |
Dr. Xiaolu Tao | Chief Development Officer | N/A | 1974 (51 år) |
Dr. Steve Arkinstall DPhil | Chief Scientific Advisor | N/A | |
Mr. Youchen Chen | VP and Head of Investor Relations & Corporate Development | ||
Mr. Bruce Zhang Ph.D. | VP & Head of Legal Affairs | ||
Dr. Ben Chih Ph.D. | Chief Scientific Officer of Neurosciences - Harbour BioMed US | ||
Dr. Michael Lee Ph.D. | Senior VP & Head of Biometrics | ||
Ms. Amy Jiang | VP, Chief of Staff & Head of Quality Department |
Adresse: China, Suzhou, Building A3 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.harbourbiomed.com
Nettsted: https://www.harbourbiomed.com